Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2012 1
2017 1
2019 1
2020 5
2021 4
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study.
Cortazar FB, Kibbelaar ZA, Glezerman IG, Abudayyeh A, Mamlouk O, Motwani SS, Murakami N, Herrmann SM, Manohar S, Shirali AC, Kitchlu A, Shirazian S, Assal A, Vijayan A, Renaghan AD, Ortiz-Melo DI, Rangarajan S, Malik AB, Hogan JJ, Dinh AR, Shin DS, Marrone KA, Mithani Z, Johnson DB, Hosseini A, Uprety D, Sharma S, Gupta S, Reynolds KL, Sise ME, Leaf DE. Cortazar FB, et al. Among authors: mamlouk o. J Am Soc Nephrol. 2020 Feb;31(2):435-446. doi: 10.1681/ASN.2019070676. Epub 2020 Jan 2. J Am Soc Nephrol. 2020. PMID: 31896554 Free PMC article.
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience.
Mamlouk O, Selamet U, Machado S, Abdelrahim M, Glass WF, Tchakarov A, Gaber L, Lahoti A, Workeneh B, Chen S, Lin J, Abdel-Wahab N, Tayar J, Lu H, Suarez-Almazor M, Tannir N, Yee C, Diab A, Abudayyeh A. Mamlouk O, et al. J Immunother Cancer. 2019 Jan 6;7(1):2. doi: 10.1186/s40425-018-0478-8. J Immunother Cancer. 2019. PMID: 30612580 Free PMC article.
Checkpoint inhibitor-related renal vasculitis and use of rituximab.
Mamlouk O, Lin JS, Abdelrahim M, Tchakarov AS, Glass WF, Selamet U, Buni M, Abdel-Wahab N, Abudayyeh A. Mamlouk O, et al. J Immunother Cancer. 2020 Jul;8(2):e000750. doi: 10.1136/jitc-2020-000750. J Immunother Cancer. 2020. PMID: 32718987 Free PMC article.
Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma.
Abudayyeh A, Lin H, Mamlouk O, Abdelrahim M, Saliba R, Rondon G, Martinez CS, Delgado R, Page V, Rajasekaran A, Sanders PW, Qazilbash M. Abudayyeh A, et al. Among authors: mamlouk o. Leuk Lymphoma. 2020 Dec;61(13):3101-3111. doi: 10.1080/10428194.2020.1797719. Epub 2020 Jul 29. Leuk Lymphoma. 2020. PMID: 32723196
Safety of CAR T-cell therapy in kidney transplant recipients.
Mamlouk O, Nair R, Iyer SP, Edwards A, Neelapu SS, Steiner RE, Adkins SA, Hawkins M, Saini N, Devashish K, Strati P, Mandayam S, Ahmed S. Mamlouk O, et al. Blood. 2021 May 6;137(18):2558-2562. doi: 10.1182/blood.2020008759. Blood. 2021. PMID: 33512386 No abstract available.
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis.
Abdelrahim M, Mamlouk O, Lin H, Lin J, Page V, Abdel-Wahab N, Swan J, Selamet U, Yee C, Diab A, Suki W, Abudayyeh A. Abdelrahim M, et al. Among authors: mamlouk o. Oncoimmunology. 2021 May 23;10(1):1927313. doi: 10.1080/2162402X.2021.1927313. Oncoimmunology. 2021. PMID: 34104543 Free PMC article.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page